Investor Advisor

Arrowhead takes aim at Wisconsin for $250M manufacturing plant: report

Arrowhead takes aim at Wisconsin for $250M manufacturing plant: report - Investor Advisor Arrowhead Pharmaceuticals, which focuses on genetic-based drugs for hard-to-treat diseases, is planning to spend $250 million to build a manufacturing campus in the Madison, Wisconsin, area. Arrowhead, which is a biopharma based in Pasadena, California, is expected to break ground on the 13-acre sit...